Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 7 | 2026 | 1881 | 1.640 |
Why?
|
| Brain Injuries, Traumatic | 4 | 2025 | 325 | 1.490 |
Why?
|
| Resilience, Psychological | 3 | 2024 | 79 | 1.170 |
Why?
|
| Fontan Procedure | 3 | 2026 | 180 | 1.120 |
Why?
|
| Sodium Lactate | 1 | 2025 | 3 | 0.900 |
Why?
|
| Lactic Acid | 2 | 2025 | 145 | 0.890 |
Why?
|
| Adaptation, Psychological | 2 | 2024 | 426 | 0.860 |
Why?
|
| Caregivers | 2 | 2024 | 589 | 0.700 |
Why?
|
| Vasodilator Agents | 1 | 2022 | 197 | 0.680 |
Why?
|
| Vascular Malformations | 1 | 2021 | 103 | 0.630 |
Why?
|
| Mental Health | 1 | 2023 | 374 | 0.620 |
Why?
|
| Pulmonary Veins | 1 | 2021 | 167 | 0.600 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2022 | 263 | 0.570 |
Why?
|
| Neural Stem Cells | 4 | 2023 | 130 | 0.570 |
Why?
|
| Cardiac Catheterization | 1 | 2022 | 631 | 0.550 |
Why?
|
| Ketone Bodies | 1 | 2017 | 41 | 0.520 |
Why?
|
| Hyperglycemia | 2 | 2017 | 233 | 0.490 |
Why?
|
| Physicians | 1 | 2022 | 626 | 0.450 |
Why?
|
| Research | 1 | 2016 | 264 | 0.430 |
Why?
|
| Patient Education as Topic | 3 | 2024 | 461 | 0.380 |
Why?
|
| Blood Glucose | 1 | 2017 | 1108 | 0.370 |
Why?
|
| Metabolomics | 1 | 2016 | 499 | 0.370 |
Why?
|
| Spinal Cord | 4 | 2023 | 256 | 0.340 |
Why?
|
| Heart Failure | 1 | 2024 | 2323 | 0.340 |
Why?
|
| Young Adult | 5 | 2026 | 9985 | 0.310 |
Why?
|
| Brain Injuries | 6 | 2015 | 703 | 0.290 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2023 | 240 | 0.280 |
Why?
|
| Adult | 12 | 2026 | 31006 | 0.250 |
Why?
|
| Adolescent | 7 | 2026 | 20803 | 0.240 |
Why?
|
| Humans | 23 | 2026 | 130042 | 0.240 |
Why?
|
| Quality of Life | 3 | 2024 | 2070 | 0.230 |
Why?
|
| Canada | 1 | 2026 | 325 | 0.220 |
Why?
|
| Cellular Reprogramming | 2 | 2023 | 127 | 0.200 |
Why?
|
| Prospective Studies | 2 | 2026 | 6392 | 0.200 |
Why?
|
| Male | 15 | 2026 | 64365 | 0.190 |
Why?
|
| Injections, Spinal | 1 | 2023 | 129 | 0.190 |
Why?
|
| Interviews as Topic | 1 | 2024 | 455 | 0.190 |
Why?
|
| Nociceptors | 1 | 2022 | 14 | 0.180 |
Why?
|
| Female | 14 | 2026 | 70230 | 0.180 |
Why?
|
| Gene Transfer Techniques | 2 | 2022 | 344 | 0.180 |
Why?
|
| Neuralgia | 1 | 2022 | 48 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 1605 | 0.170 |
Why?
|
| Cyanosis | 1 | 2021 | 41 | 0.170 |
Why?
|
| Stem Cell Transplantation | 1 | 2023 | 224 | 0.170 |
Why?
|
| Registries | 2 | 2026 | 1606 | 0.170 |
Why?
|
| Qualitative Research | 1 | 2024 | 710 | 0.160 |
Why?
|
| Pia Mater | 1 | 2019 | 9 | 0.160 |
Why?
|
| Parenchymal Tissue | 1 | 2019 | 8 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2026 | 3775 | 0.160 |
Why?
|
| Heart Diseases | 1 | 2024 | 499 | 0.150 |
Why?
|
| Multipotent Stem Cells | 1 | 2019 | 28 | 0.150 |
Why?
|
| Gene Silencing | 1 | 2019 | 229 | 0.150 |
Why?
|
| Motor Neurons | 1 | 2019 | 133 | 0.150 |
Why?
|
| Intracranial Pressure | 2 | 2010 | 214 | 0.140 |
Why?
|
| Biopsy | 1 | 2022 | 1240 | 0.140 |
Why?
|
| Nerve Degeneration | 1 | 2019 | 128 | 0.140 |
Why?
|
| Exercise | 1 | 2024 | 865 | 0.140 |
Why?
|
| Dependovirus | 1 | 2019 | 159 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2019 | 158 | 0.140 |
Why?
|
| Heart Transplantation | 1 | 2024 | 839 | 0.130 |
Why?
|
| Child | 5 | 2026 | 26172 | 0.130 |
Why?
|
| Swine | 4 | 2023 | 1183 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 2 | 2010 | 481 | 0.130 |
Why?
|
| Chromatography, Gas | 1 | 2016 | 20 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2019 | 765 | 0.120 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 240 | 0.120 |
Why?
|
| Electron Transport Complex III | 1 | 2015 | 4 | 0.120 |
Why?
|
| Electron Transport Complex II | 1 | 2015 | 7 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2025 | 5034 | 0.120 |
Why?
|
| Middle Aged | 7 | 2025 | 28296 | 0.110 |
Why?
|
| Echocardiography | 1 | 2021 | 1130 | 0.110 |
Why?
|
| Diet, Ketogenic | 1 | 2015 | 26 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 254 | 0.110 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 232 | 0.110 |
Why?
|
| Liver | 1 | 2022 | 1783 | 0.110 |
Why?
|
| Brain | 4 | 2023 | 3144 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 358 | 0.110 |
Why?
|
| Astrocytes | 1 | 2017 | 268 | 0.110 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2013 | 19 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2026 | 12823 | 0.100 |
Why?
|
| Rats | 4 | 2023 | 3371 | 0.100 |
Why?
|
| United States | 2 | 2026 | 11891 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 789 | 0.080 |
Why?
|
| Pulse | 1 | 2010 | 28 | 0.080 |
Why?
|
| Glucose | 2 | 2006 | 851 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2010 | 165 | 0.080 |
Why?
|
| Blood Flow Velocity | 1 | 2010 | 416 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2013 | 552 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17536 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8545 | 0.070 |
Why?
|
| Biomarkers | 1 | 2017 | 3355 | 0.070 |
Why?
|
| Microdialysis | 2 | 2006 | 59 | 0.060 |
Why?
|
| Atrophy | 2 | 2019 | 246 | 0.060 |
Why?
|
| Infant | 1 | 2021 | 13265 | 0.060 |
Why?
|
| Animals | 6 | 2023 | 33638 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 4035 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2003 | 79 | 0.050 |
Why?
|
| Program Development | 1 | 2024 | 179 | 0.050 |
Why?
|
| Sendai virus | 1 | 2023 | 4 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1907 | 0.050 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2023 | 38 | 0.050 |
Why?
|
| Spinal Cord Dorsal Horn | 1 | 2022 | 2 | 0.050 |
Why?
|
| Posterior Horn Cells | 1 | 2022 | 4 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2023 | 146 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 476 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2024 | 819 | 0.040 |
Why?
|
| Insulin | 1 | 2006 | 1144 | 0.040 |
Why?
|
| Graft Survival | 1 | 2023 | 462 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 2322 | 0.040 |
Why?
|
| Health Promotion | 1 | 2024 | 413 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1439 | 0.040 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2019 | 24 | 0.040 |
Why?
|
| Evoked Potentials, Motor | 1 | 2019 | 28 | 0.040 |
Why?
|
| Primates | 1 | 2019 | 81 | 0.040 |
Why?
|
| Muscle Development | 1 | 2019 | 72 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2023 | 892 | 0.040 |
Why?
|
| Protein Folding | 1 | 2019 | 214 | 0.040 |
Why?
|
| Longevity | 1 | 2020 | 175 | 0.040 |
Why?
|
| Transplantation, Isogeneic | 1 | 2018 | 14 | 0.040 |
Why?
|
| Neostriatum | 1 | 2018 | 8 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2018 | 53 | 0.030 |
Why?
|
| Interneurons | 1 | 2019 | 144 | 0.030 |
Why?
|
| Telemedicine | 1 | 2024 | 524 | 0.030 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2017 | 8 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 73 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 662 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2018 | 150 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1109 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 157 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2018 | 668 | 0.030 |
Why?
|
| Free Radicals | 1 | 2015 | 35 | 0.030 |
Why?
|
| Ketones | 1 | 2015 | 26 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 1085 | 0.030 |
Why?
|
| Proteome | 1 | 2017 | 287 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2017 | 448 | 0.030 |
Why?
|
| Skin | 1 | 2018 | 538 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 271 | 0.030 |
Why?
|
| Brain Concussion | 1 | 2017 | 248 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 484 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1481 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 584 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 2330 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2552 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 850 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 2550 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2018 | 1241 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 2192 | 0.020 |
Why?
|
| Antioxidants | 1 | 2015 | 331 | 0.020 |
Why?
|
| Inflammation | 1 | 2019 | 1477 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2883 | 0.020 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2010 | 6 | 0.020 |
Why?
|
| Survivors | 1 | 2013 | 345 | 0.020 |
Why?
|
| Aging | 1 | 2018 | 1237 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 110 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 4689 | 0.020 |
Why?
|
| Software Design | 1 | 2010 | 21 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2010 | 90 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2010 | 71 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 768 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 142 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 413 | 0.020 |
Why?
|
| Neurons | 1 | 2018 | 1978 | 0.020 |
Why?
|
| Cognition | 1 | 2013 | 816 | 0.020 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2006 | 12 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 6167 | 0.010 |
Why?
|
| Critical Care | 1 | 2010 | 686 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 18145 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 532 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2006 | 183 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2006 | 759 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 1662 | 0.010 |
Why?
|
| Glasgow Coma Scale | 1 | 2003 | 200 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 242 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1373 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 20805 | 0.010 |
Why?
|